[1] |
ZHOU Yixi, LI Yongjia, LAN Tingyu, CHENG Linggang, HE Wen, DU Lijuan.
A Case of Childhood Stroke Caused by Ebstein’s Anomaly Combined with Atrial Septal Defect
[J]. Chinese Journal of Stroke, 2023, 18(11): 1303-1306.
|
[2] |
JIANG Xiaoqing, WENG Jiaxu, ZHOU Hongyu, LI Zixiao, WANG Yongjun.
Advances in Correlation between DNA Methylation and Non-Large Artery Atherosclerotic Stroke
[J]. Chinese Journal of Stroke, 2023, 18(04): 376-387.
|
[3] |
YANG Muwei, LIU Gao, HE Yixian, GUO Qingyuan, CAI Enli.
Pooled Analysis of Best Evidences of Prevention of Pulmonary Embolism in Patients with Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(12): 1259-1267.
|
[4] |
YANG Mu-Wei, LIU Gao, HE Yi-Xian, GUO Qing-Yuan, CAI En-Li.
Mechanical Prophylaxis for Venous Thromboembolism in Stroke Patients: A Meta-analysis
[J]. Chinese Journal of Stroke, 2021, 16(11): 1115-1122.
|
[5] |
GAO Hao-Ran, WANG Yan, DUAN Yu-Qing, XU Shan-Shan, MIAO Ming-Yue, CHENG Kun-Ming, ZHOU Jian-Xin, ZHANG Lin-Lin.
Incidence, Risk Factors and In-hospital Outcome of Venous Thromboembolism in Neurocritical Patients
[J]. Chinese Journal of Stroke, 2021, 16(07): 694-698.
|
[6] |
CHEN Zhu-Lin, HUANG Guang.
Progress in Patent Foramen Ovale and Cryptogenic Stroke
[J]. Chinese Journal of Stroke, 2019, 14(05): 457-462.
|
[7] |
TANG Yu, HUANG Guang.
Nonbacterial Thromboendocarditis and Stroke
[J]. Chinese Journal of Stroke, 2019, 14(05): 463-467.
|
[8] |
FAN Xue-Hui, ZHONG Di, CHEN Hong-Ping, LI Guo-Zhong, ZHAO Xiu-Li.
Advance in Treatment of Patent Foramen Ovale and Clinical Application of Paradoxical Embolism Risk Scale
[J]. Chinese Journal of Stroke, 2018, 13(12): 1321-1326.
|
[9] |
ZHOU Teng-Fei, ZHU Liang-Fu,LI Tian-Xiao, et al..
Study on the Difference of Response to Endovascular Recanalization Treatment of Large Vessel Occlusion: Intracranial Atherosclerosis versus Cardioembolism
[J]. Chinese Journal of Stroke, 2017, 12(07): 579-583.
|
[10] |
HUO Kang, YUAN Xing-Yun, CHEN Chen, et al..
Progress of Mechanism and Treatment of Fat Embolism Stroke
[J]. Chinese Journal of Stroke, 2017, 12(07): 620-623.
|
[11] |
WU Zhang-Wei, MEI Li-Ping, ZHAO Jun, et al..
Observation of the Status of Anticoagulation and Analysis of Hemorrhagic Transformation of Cerebral Embolism Patients with Atrial Fibrillation
[J]. Chinese Journal of Stroke, 2016, 11(01): 47-53.
|
[12] |
HAN Yi-Hua, XING Ying-Qi, CHEN Jia-Feng..
Study Progress on Etiology of Cryptogenic Stroke
[J]. Chinese Journal of Stroke, 2015, 10(08): 695-700.
|
[13] |
ZHENG Hua-Guang*, WANG Yi-Long,Xiao-Chun, LU Jing-Jing, JU Yi, ZHANG Ning,NING Bin, HE Wen, FU Qiang, CHEN Bu-Xing, LIU Li-Ping, YANG Zhong-Hua, WANGChun-Xue, DONG Ke-Hui, ZHAO Xing-Quan, WANG Yong-Ju.
Risk of Paradoxical Embolism Score in Cryptogenic Stroke Patients or Tansient
Ischemic Attack with Patent Foramen Ovale
[J]. Chinese Journal of Stroke, 2014, 9(08): 654-662.
|
[14] |
TANG Shu, YAN Li-Rong, SUN Yu-Heng, CHEN Jie, HU Hong-Tao..
Effectiveness and Safety of Thrombolytic Therapy for Cardiogenic Cerebral Embolism by Intravenous Recombinant Tissue Plasminogen Activator
[J]. Chinese Journal of Stroke, 2013, 8(05): 360-367.
|
[15] |
CHEN Jie;GAO Shan;HU Ying-Huan.
Microembolic Signals in Patients with Moyamoya Disease:Relationship with Clinical Manifestation and Infarctions
[J]. , 2012, 7(07): 531-536.
|